Insulia_Blog_HeaderImage_Revised_6-MAR-19_FINAL_1

Translating the Science of Digital Insulin Titration into Practice

Mar 13, 2019 11:32:28 AM / by Barbara Eichorst, MS, RD, CDE posted in titration, cde, hcp, pwd, insulin optimization, insulin affordability, insulin therapy, medication optimization, dsmes, digital insulin titration, insulin titration

0 Comments

Years ago, when I was working as a dietitian at a diabetes clinic, part of my job was to help people with type 2 diabetes (PWD-T2) titrate their insulin. Being a dietitian, most of the adjustments were related to meal planning, like manipulating food to achieve desirable glucose goals. PWD and I were figuring out the carb to insulin ratio, the right amount of protein vs. fat, and meal/snack timing. Unfortunately, the insulin adjustment conversations always ended in “Talk to your doctor about your insulin adjustment.”

Read More
Insulia® is a prescription-only software medical device intended for use by healthcare professionals and their type 2 adult diabetes patients treated with long-acting insulin analogs as an aid in the management of diabetes. Please carefully read product instructions before use. Insulia is only indicated for use with insulin detemir (Levemir® U-100) once or twice daily, insulin degludec (Tresiba® U-100) once daily and insulin glargine (Lantus® U-100, Toujeo® U-300 and Basaglar® U-100) once daily. Insulia should not be used for basal dose recommendations with intermediate-acting insulin (NPH – Neutral Protamine Hagedorn) nor with premixed insulin. Insulia is not intended for use by pregnant women, non-adult patients or patients that are treated with a basal-plus or a basal-bolus regimen (i.e. including multiple mealtime insulin injections per day or insulin pump therapy).
 
©2019 Voluntis. All rights reserved. For distribution in US only. Insulia is a registered trademark of Voluntis.